ResearcherXiangya Hospital Central South UniversityActive in the last 2 years

Wei Wei

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5133956203. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 2 papers

Papers 2

Extrapancreatic extension modifies chemotherapy benefit in resected pancreatic ductal adenocarcinoma: a population-based cohort study. Last author DOI 10.1038/s41598-026-47990-w ↗
Extrapancreatic extension exhibits tumor size-dependent prognostic impact in pancreatic cancer. Co-author DOI 10.1038/s41598-026-60797-z ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xuejun Gong · 1 shared paper, 2026 · strength 0.39
- Paper Extrapancreatic extension modifies chemotherapy benefit in resected pancreatic ductal adenocarcinoma: a population-base… DOI 10.1038/s41598-026-47990-w ↗
Jun Zhou · 1 shared paper, 2026 · strength 0.39
- Paper Extrapancreatic extension exhibits tumor size-dependent prognostic impact in pancreatic cancer. DOI 10.1038/s41598-026-60797-z ↗
Shuai Liang · 1 shared paper, 2026 · strength 0.39
- Paper Extrapancreatic extension modifies chemotherapy benefit in resected pancreatic ductal adenocarcinoma: a population-base… DOI 10.1038/s41598-026-47990-w ↗
Ling Tang · 1 shared paper, 2026 · strength 0.39
- Paper Extrapancreatic extension exhibits tumor size-dependent prognostic impact in pancreatic cancer. DOI 10.1038/s41598-026-60797-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.